Which has the lower trailing P/E, ABBV or ELV?

ELV has the lower trailing P/E: ABBV trades at 72.43 and ELV at 18.61. P/E is one valuation measure and does not by itself establish which business is cheaper.

Which has grown faster, ABBV or ELV?

Over the past five years, ELV grew revenue faster — ABBV at a 3.69% CAGR versus ELV at 9.25%.

Does ABBV or ELV pay a bigger dividend?

ABBV yields 2.68% and ELV yields 1.65% based on trailing dividends and the latest price.

Is ABBV or ELV more profitable?

ABBV runs the higher net margin — ABBV at 9.81% versus ELV at 2.47%.

How have ABBV and ELV total returns compared?

Over the past 10 years, ABBV delivered 19.76% and ELV delivered 14.18% annualized total return. Past performance doesn't predict future results.

AbbVie Inc. (ABBV) vs Elevance Health Inc. (ELV)

A side-by-side comparison of AbbVie Inc. and Elevance Health Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of September 10, 2026. Differences are shown without an overall score or investment verdict.

ABBV

AbbVie Inc.

$454.17B

$257.06HealthcareDelayed quote: Sep 11, 2026, 4:00 PM EDT

ELV

Elevance Health Inc.

$90.81B

$418.72HealthcareDelayed quote: Sep 11, 2026, 4:00 PM EDT

Total return — ABBV vs ELV

growth of $100 · dividends reinvested · last 10y

ABBV +507.0% (+19.8%/yr)ELV +284.4% (+14.4%/yr)ABBV compounded faster over this window

ABBV ELV

ABBV vs ELV: by the numbers

•ABBV is the larger company ($454.17B vs $90.81B market cap).
•ELV trades at the lower trailing earnings multiple (18.61 vs 72.43 P/E), one valuation lens rather than an overall verdict.
•ABBV converts more revenue to profit (9.81% vs 2.47% net margin).
•ELV grew revenue faster over the past five years (9.25% vs 3.69% CAGR).
•ABBV pays the higher dividend yield (2.68% vs 1.65%).

Metrics side by side

Valuation

Metric	ABBV	ELV
P/E ratio	72.43	18.61
Forward P/E	18.32	15.42
P/S ratio	7.05	0.45
P/B ratio	N/A	2.02
EV / EBITDA	19.34	13.82
FCF yield	3.99%	6.93%

Profitability

Metric	ABBV	ELV
Gross margin	71.48%	25.56%
Operating margin	29.32%	3.51%
Net margin	9.81%	2.47%
ROE	N/A	11.06%
ROIC	13.46%	6.34%

Dividends

Metric	ABBV	ELV
Dividend yield	2.68%	1.65%
Payout ratio	192.43%	30.49%

Growth (annualized)

Metric	ABBV	ELV
Revenue CAGR (5Y)	3.69%	9.25%
EPS CAGR (5Y)	-2.79%	6.67%
FCF CAGR (5Y)	0.11%	-19.97%
Total return CAGR (5Y)	23.51%	4.62%

Frequently asked

Which has the lower trailing P/E, ABBV or ELV?: ELV has the lower trailing P/E: ABBV trades at 72.43 and ELV at 18.61. P/E is one valuation measure and does not by itself establish which business is cheaper.
Which has grown faster, ABBV or ELV?: Over the past five years, ELV grew revenue faster — ABBV at a 3.69% CAGR versus ELV at 9.25%.
Does ABBV or ELV pay a bigger dividend?: ABBV yields 2.68% and ELV yields 1.65% based on trailing dividends and the latest price.
Is ABBV or ELV more profitable?: ABBV runs the higher net margin — ABBV at 9.81% versus ELV at 2.47%.
How have ABBV and ELV total returns compared?: Over the past 10 years, ABBV delivered 19.76% and ELV delivered 14.18% annualized total return. Past performance doesn't predict future results.

Go deeper

Full ABBV analysis Full ELV analysis Interactive comparison tool

Dig into the metrics

AbbVie P/E ratio Elevance Health P/E ratio AbbVie dividend yield Elevance Health dividend yield AbbVie ROE Elevance Health ROE AbbVie operating margin Elevance Health operating margin AbbVie revenue growth Elevance Health revenue growth AbbVie free cash flow Elevance Health free cash flow

AbbVie & Elevance Health appear in these rankings

Highest Dividend Yield Stocks 25+ Year Dividend Growers Highest FCF Yield Stocks Highest 10-Year Total Return Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified September 10, 2026.